tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Similar Stocks

Compare
958 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Taysha Gene Therapies
$1.64
$327.91M
-35.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Bluebird Bio
$7.04
$68.44M
-70.17%
1 Buy
4 Hold
0 Sell
Hold
uniQure
$12.96
$692.55M
106.37%
8 Buy
2 Hold
0 Sell
Strong Buy
Editas Medicine
$2.06
$170.05M
-74.02%
4 Buy
9 Hold
2 Sell
Hold
Intellia Therapeutics
$12.25
$1.17B
-54.93%
11 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$50.43
$4.48B
-41.49%
12 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
TSHA
Taysha Gene Therapies
1.64
-0.91
-35.69%
BLUE
Bluebird Bio
7.04
-16.56
-70.17%
QURE
uniQure
12.96
6.68
106.37%
EDIT
Editas Medicine
2.06
-5.87
-74.02%
NTLA
Intellia Therapeutics
12.25
-14.93
-54.93%
CRSP
Crispr Therapeutics AG
50.43
-35.76
-41.49%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis